All sponsors

Jemincare

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS6
PHASE 3 / 2-33
RECRUITING3
READOUTS ≤12 MONTHS3
Open Jemincare on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
JYB1904
NCT06509334
P2RecruitingChronic Spontaneous Urticaria1352026-07-15
JMKX003142 will be administered orally
NCT06800651
P2RecruitingADPKD (Autosomal Dominant Polycystic Kidney Disease)1352027-02-28
JYB1904
NCT07402213
P3RecruitingChronic Spontaneous Urticaria2402027-06-07
JYB1904
NCT07459452
P2Not yet recruitingPerennial Allergic Rhinitis1352027-10
JMKX001899
NCT07242274
P3Not yet recruitingNSCLC (Non-small Cell Lung Cancer)4722027-12-31
JMKX003142 Tablets
NCT07841093
P3Not yet recruitingRenal Edema; Nephrogenic Edema2402028-04-30